Skip to content
10-K

Annual Report

EVOKE PHARMA, INC.

0000950170-25-038712

← back to feed
Filed
Mar 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 3, 2025 1.49M sh
Shares Diluted FY 2024 · Dec 31, 2024 1.91M sh
Operating Cash Flow FY 2024 · Dec 31, 2024 −$5.46M
Cash And Equivalents FY 2024 · Dec 31, 2024 $13.6M
Stockholders Equity FY 2024 · Dec 31, 2024 $7.04M
Current Liabilities FY 2024 · Dec 31, 2024 $10.38M
Total Liabilities FY 2024 · Dec 31, 2024 $10.48M
Current Assets FY 2024 · Dec 31, 2024 $17.24M
Total Assets FY 2024 · Dec 31, 2024 $17.52M
Eps Diluted FY 2024 · Dec 31, 2024 −$2.81
Eps Basic FY 2024 · Dec 31, 2024 −$2.81
Sga Expense FY 2024 · Dec 31, 2024 $15.08M
Net Income FY 2024 · Dec 31, 2024 −$5.35M
Operating Income FY 2024 · Dec 31, 2024 −$5.2M
Revenue FY 2024 · Dec 31, 2024 $10.25M